{"id":"W4408144500","doi":"10.1177/22143602241305511","title":"Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions","year":2025,"lang":"en","type":"article","venue":"Journal of Neuromuscular Diseases","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"Sanofi Genzyme; Genentech; Grifols; Japan Blood Products Organization; Regeneron Pharmaceuticals; Alexion Pharmaceuticals; Biogen; Novo Nordisk; Sanofi; AstraZeneca; Pfizer; Amgen","keywords":"Myasthenia gravis; Medicine; Interim analysis; Adverse effect; Internal medicine; Neuromuscular disease; Autoantibody; Clinical trial; Antibody; Immunology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003183456,0.0001881844,0.0009638817,0.0007552266,0.0001103328,0.00006426933,0.0003735457,0.00003111994,0.00002813037],"category_scores_gemma":[0.0003434335,0.0001184489,0.0003596941,0.001492839,0.00007490213,0.0001181665,0.0002892775,0.0002357339,2.522019e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003319016,"about_ca_system_score_gemma":0.0002028139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001006098,"about_ca_topic_score_gemma":0.00006085119,"domain_scores_codex":[0.997969,0.0003576508,0.0008008801,0.0002483805,0.0004369681,0.0001870917],"domain_scores_gemma":[0.998569,0.00008591909,0.0003898093,0.000536666,0.0002439664,0.0001746611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005448252,0.0231575,0.8585223,0.0001779236,0.0118319,0.002376363,0.001244124,0.0006583281,0.07448128,0.0006489407,0.0003251352,0.02112797],"study_design_scores_gemma":[0.02937412,0.0008290336,0.9479727,0.0003400811,0.01743039,0.00007050255,0.0005212144,0.002549096,0.0002582334,0.0003596016,0.000171076,0.0001239696],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959671,0.002491027,0.00003589681,0.0007232556,0.0001257262,0.000583655,0.00002005762,0.000005890046,0.00004740779],"genre_scores_gemma":[0.9992402,0.0001133751,0.0001049071,0.0003992998,0.00003137772,0.000009123044,0.000003297016,0.0000158772,0.00008252174],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08945041,"threshold_uncertainty_score":0.4830205,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02857169951259211,"score_gpt":0.3718732683308484,"score_spread":0.3433015688182563,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}